

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.08668714 |
| 2 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.11478283 |
| 3 | actin filament-based movement (GO:0030048) | 6.10298276 |
| 4 | creatine metabolic process (GO:0006600) | 5.99241482 |
| 5 | myofibril assembly (GO:0030239) | 5.96803186 |
| 6 | striated muscle contraction (GO:0006941) | 5.68984055 |
| 7 | regulation of relaxation of muscle (GO:1901077) | 5.60991202 |
| 8 | response to muscle activity (GO:0014850) | 5.59637611 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.52281301 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.52281301 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.41907235 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.39091387 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 5.39091387 |
| 14 | lysine catabolic process (GO:0006554) | 5.30823568 |
| 15 | lysine metabolic process (GO:0006553) | 5.30823568 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.13680682 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.12291747 |
| 18 | NADH metabolic process (GO:0006734) | 4.92565755 |
| 19 | cardiac myofibril assembly (GO:0055003) | 4.92310389 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 4.81163177 |
| 21 | skeletal muscle adaptation (GO:0043501) | 4.77555094 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.73182563 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.72734542 |
| 24 | kynurenine metabolic process (GO:0070189) | 4.71653956 |
| 25 | skeletal muscle fiber development (GO:0048741) | 4.58826619 |
| 26 | cysteine metabolic process (GO:0006534) | 4.57757149 |
| 27 | glycogen catabolic process (GO:0005980) | 4.55147347 |
| 28 | carnitine shuttle (GO:0006853) | 4.53888913 |
| 29 | response to inactivity (GO:0014854) | 4.53368132 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.51150804 |
| 31 | aspartate family amino acid catabolic process (GO:0009068) | 4.47804907 |
| 32 | muscle contraction (GO:0006936) | 4.44095658 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 4.43485820 |
| 34 | actomyosin structure organization (GO:0031032) | 4.43372273 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.37946000 |
| 36 | 2-oxoglutarate metabolic process (GO:0006103) | 4.36846414 |
| 37 | cardiac muscle contraction (GO:0060048) | 4.35006288 |
| 38 | glucan catabolic process (GO:0009251) | 4.33287040 |
| 39 | tryptophan catabolic process (GO:0006569) | 4.32611198 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 4.32611198 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 4.32611198 |
| 42 | actin-myosin filament sliding (GO:0033275) | 4.27107145 |
| 43 | muscle filament sliding (GO:0030049) | 4.27107145 |
| 44 | fructose metabolic process (GO:0006000) | 4.26361005 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.26233726 |
| 46 | glycine metabolic process (GO:0006544) | 4.17423888 |
| 47 | myotube cell development (GO:0014904) | 4.16781293 |
| 48 | plasma membrane repair (GO:0001778) | 4.10366291 |
| 49 | fatty acid beta-oxidation (GO:0006635) | 4.09944772 |
| 50 | regulation of skeletal muscle contraction (GO:0014819) | 4.09870979 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.06945953 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.06456960 |
| 53 | tryptophan metabolic process (GO:0006568) | 4.06413549 |
| 54 | cellular polysaccharide catabolic process (GO:0044247) | 4.05547646 |
| 55 | bile acid biosynthetic process (GO:0006699) | 4.01521834 |
| 56 | short-chain fatty acid metabolic process (GO:0046459) | 3.98566959 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 3.96489919 |
| 58 | acetyl-CoA metabolic process (GO:0006084) | 3.96413991 |
| 59 | muscle system process (GO:0003012) | 3.94777507 |
| 60 | regulation of actin filament-based movement (GO:1903115) | 3.86907545 |
| 61 | branched-chain amino acid catabolic process (GO:0009083) | 3.84070596 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 3.83218770 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 3.81362697 |
| 64 | cytidine metabolic process (GO:0046087) | 3.79413536 |
| 65 | cytidine catabolic process (GO:0006216) | 3.79413536 |
| 66 | cytidine deamination (GO:0009972) | 3.79413536 |
| 67 | sarcomere organization (GO:0045214) | 3.78845716 |
| 68 | urea cycle (GO:0000050) | 3.78492447 |
| 69 | urea metabolic process (GO:0019627) | 3.78492447 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 3.77320386 |
| 71 | alpha-linolenic acid metabolic process (GO:0036109) | 3.76979899 |
| 72 | tricarboxylic acid cycle (GO:0006099) | 3.75616164 |
| 73 | regulation of triglyceride catabolic process (GO:0010896) | 3.72995993 |
| 74 | oxidative phosphorylation (GO:0006119) | 3.72175449 |
| 75 | fatty acid oxidation (GO:0019395) | 3.71302491 |
| 76 | carnitine metabolic process (GO:0009437) | 3.69599590 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 3.68451037 |
| 78 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.68021327 |
| 79 | striated muscle atrophy (GO:0014891) | 3.66249674 |
| 80 | fatty acid catabolic process (GO:0009062) | 3.64441959 |
| 81 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.63353028 |
| 82 | striated muscle adaptation (GO:0014888) | 3.62913448 |
| 83 | lipid oxidation (GO:0034440) | 3.62804881 |
| 84 | regulation of cell communication by electrical coupling (GO:0010649) | 3.62471417 |
| 85 | ethanol oxidation (GO:0006069) | 3.61872836 |
| 86 | cardiac muscle hypertrophy (GO:0003300) | 3.61679451 |
| 87 | polysaccharide catabolic process (GO:0000272) | 3.61168277 |
| 88 | biotin metabolic process (GO:0006768) | 3.60663346 |
| 89 | glucan biosynthetic process (GO:0009250) | 3.59627658 |
| 90 | glycogen biosynthetic process (GO:0005978) | 3.59627658 |
| 91 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.59253686 |
| 92 | aromatic amino acid family metabolic process (GO:0009072) | 3.56951858 |
| 93 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.55054818 |
| 94 | coenzyme catabolic process (GO:0009109) | 3.54389426 |
| 95 | valine metabolic process (GO:0006573) | 3.54099104 |
| 96 | bile acid and bile salt transport (GO:0015721) | 3.53756132 |
| 97 | branched-chain amino acid metabolic process (GO:0009081) | 3.52869500 |
| 98 | nitrogen cycle metabolic process (GO:0071941) | 3.52548300 |
| 99 | regulation of fibrinolysis (GO:0051917) | 3.51528836 |
| 100 | skeletal muscle tissue development (GO:0007519) | 3.50325787 |
| 101 | regulation of protein activation cascade (GO:2000257) | 3.50062360 |
| 102 | gluconeogenesis (GO:0006094) | 3.49951548 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.49735805 |
| 104 | organic acid catabolic process (GO:0016054) | 3.49735805 |
| 105 | triglyceride homeostasis (GO:0070328) | 3.48934607 |
| 106 | acylglycerol homeostasis (GO:0055090) | 3.48934607 |
| 107 | monocarboxylic acid catabolic process (GO:0072329) | 3.48082134 |
| 108 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.47378202 |
| 109 | ketone body metabolic process (GO:1902224) | 3.46996121 |
| 110 | actin-mediated cell contraction (GO:0070252) | 3.45832631 |
| 111 | protein carboxylation (GO:0018214) | 3.45449210 |
| 112 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.45449210 |
| 113 | high-density lipoprotein particle remodeling (GO:0034375) | 3.45114369 |
| 114 | striated muscle hypertrophy (GO:0014897) | 3.44602448 |
| 115 | carnitine transport (GO:0015879) | 3.44189579 |
| 116 | amino-acid betaine transport (GO:0015838) | 3.44189579 |
| 117 | bile acid metabolic process (GO:0008206) | 3.43959552 |
| 118 | muscle fiber development (GO:0048747) | 3.43853960 |
| 119 | carnitine transmembrane transport (GO:1902603) | 3.43288734 |
| 120 | serine family amino acid biosynthetic process (GO:0009070) | 3.42534398 |
| 121 | complement activation, alternative pathway (GO:0006957) | 3.39770295 |
| 122 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.35739579 |
| 123 | negative regulation of cholesterol transport (GO:0032375) | 3.34634863 |
| 124 | negative regulation of sterol transport (GO:0032372) | 3.34634863 |
| 125 | phospholipid homeostasis (GO:0055091) | 3.32718486 |
| 126 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.29617661 |
| 127 | regulation of complement activation (GO:0030449) | 3.29079821 |
| 128 | muscle cell fate commitment (GO:0042693) | 3.29069969 |
| 129 | hexose biosynthetic process (GO:0019319) | 3.26649524 |
| 130 | muscle tissue morphogenesis (GO:0060415) | 3.24684629 |
| 131 | glutamate metabolic process (GO:0006536) | 3.24683931 |
| 132 | muscle atrophy (GO:0014889) | 3.23842056 |
| 133 | drug catabolic process (GO:0042737) | 3.18933135 |
| 134 | regulation of cholesterol homeostasis (GO:2000188) | 3.18913821 |
| 135 | cellular glucuronidation (GO:0052695) | 3.17689235 |
| 136 | imidazole-containing compound metabolic process (GO:0052803) | 3.16613327 |
| 137 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.16092768 |
| 138 | regulation of striated muscle contraction (GO:0006942) | 3.14387129 |
| 139 | glycogen metabolic process (GO:0005977) | 3.14114326 |
| 140 | response to mercury ion (GO:0046689) | 3.13408963 |
| 141 | negative regulation of protein localization to cell surface (GO:2000009) | 3.11662029 |
| 142 | alkaloid metabolic process (GO:0009820) | 3.10687212 |
| 143 | muscle cell cellular homeostasis (GO:0046716) | 3.10105912 |
| 144 | regulation of cholesterol esterification (GO:0010872) | 3.10062323 |
| 145 | cellular glucan metabolic process (GO:0006073) | 3.09542445 |
| 146 | glucan metabolic process (GO:0044042) | 3.09542445 |
| 147 | muscle hypertrophy (GO:0014896) | 3.09120890 |
| 148 | epoxygenase P450 pathway (GO:0019373) | 3.07554917 |
| 149 | drug transmembrane transport (GO:0006855) | 3.07492735 |
| 150 | tyrosine metabolic process (GO:0006570) | 3.07103708 |
| 151 | skeletal muscle contraction (GO:0003009) | 3.05630949 |
| 152 | oxaloacetate metabolic process (GO:0006107) | 3.04495393 |
| 153 | ethanol metabolic process (GO:0006067) | 3.03601417 |
| 154 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.01816653 |
| 155 | positive regulation of myotube differentiation (GO:0010831) | 2.97193803 |
| 156 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.95387432 |
| 157 | exogenous drug catabolic process (GO:0042738) | 2.94327032 |
| 158 | muscle adaptation (GO:0043500) | 2.88053489 |
| 159 | cellular carbohydrate catabolic process (GO:0044275) | 2.84847369 |
| 160 | response to activity (GO:0014823) | 2.82457154 |
| 161 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.82102783 |
| 162 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.81676250 |
| 163 | muscle structure development (GO:0061061) | 2.80870736 |
| 164 | regulation of the force of heart contraction (GO:0002026) | 2.80121221 |
| 165 | muscle organ development (GO:0007517) | 2.79735864 |
| 166 | monosaccharide biosynthetic process (GO:0046364) | 2.78410504 |
| 167 | regulation of sequestering of triglyceride (GO:0010889) | 2.77677191 |
| 168 | skeletal muscle tissue regeneration (GO:0043403) | 2.77241503 |
| 169 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.75600455 |
| 170 | striated muscle cell development (GO:0055002) | 2.74217007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.47764799 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.76538922 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.46097593 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.42593177 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.40014538 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.04889424 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.45007278 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.16761878 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.08298720 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.84005746 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.48398431 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.44651293 |
| 13 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.35819295 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.33346899 |
| 15 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.23384550 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.11663793 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.11107652 |
| 18 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.04274879 |
| 19 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.00784016 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00237216 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.82673811 |
| 22 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.79118415 |
| 23 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.79118415 |
| 24 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.79118415 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74039299 |
| 26 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.70039299 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68269600 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66089272 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.59490385 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54669333 |
| 31 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51938010 |
| 32 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.51653988 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45580753 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45522319 |
| 35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.42921163 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42262026 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41884978 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39435190 |
| 39 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.37347105 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.37044675 |
| 41 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.33389691 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33307425 |
| 43 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32800131 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31945726 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28639097 |
| 46 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.28064545 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27280092 |
| 48 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.25723882 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25651653 |
| 50 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.23843559 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23623534 |
| 52 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.17810152 |
| 53 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17661632 |
| 54 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17661632 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17092005 |
| 56 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.15672262 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12683787 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12237710 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12000745 |
| 60 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.11985286 |
| 61 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11416841 |
| 62 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10602378 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09453650 |
| 64 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08218033 |
| 65 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.06692357 |
| 66 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.06112537 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05920357 |
| 68 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05616973 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05322287 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04150496 |
| 71 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04049172 |
| 72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03152260 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02751816 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02728638 |
| 75 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02244441 |
| 76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00570397 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00256592 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99681490 |
| 79 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99187885 |
| 80 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.99088051 |
| 81 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98889571 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.98865786 |
| 83 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98776072 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97875202 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97431570 |
| 86 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97199738 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96706461 |
| 88 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.96676581 |
| 89 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94581709 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94236428 |
| 91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93463149 |
| 92 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93004085 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91500111 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91208832 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90937569 |
| 96 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89957248 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89943809 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89788770 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89067901 |
| 100 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.88583286 |
| 101 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88463584 |
| 102 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88112377 |
| 103 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.87606733 |
| 104 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.87246575 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86926928 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86877236 |
| 107 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.86639640 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86180452 |
| 109 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.85895589 |
| 110 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.85624580 |
| 111 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85529481 |
| 112 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.85489460 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85285435 |
| 114 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84434050 |
| 115 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.84094531 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83682375 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83543565 |
| 118 | * P68_20966046_ChIP-Seq_HELA_Human | 0.83488714 |
| 119 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83090750 |
| 120 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.82372902 |
| 121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82312276 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.82041971 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80867344 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.79622082 |
| 125 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.79484589 |
| 126 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79257786 |
| 127 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.79195259 |
| 128 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.79023300 |
| 129 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.78856911 |
| 130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78024037 |
| 131 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77623414 |
| 132 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.77078459 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.75303455 |
| 134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74013962 |
| 135 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.73605303 |
| 136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.73397890 |
| 137 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72921414 |
| 138 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.72200143 |
| 139 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.72108270 |
| 140 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71567279 |
| 141 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.71297166 |
| 142 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.70935790 |
| 143 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.70870727 |
| 144 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.70826963 |
| 145 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70746072 |
| 146 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70717009 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70433547 |
| 148 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69998372 |
| 149 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.69827164 |
| 150 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69803299 |
| 151 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.69675885 |
| 152 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69309589 |
| 153 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.69253156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.26461345 |
| 2 | MP0005360_urolithiasis | 5.10974002 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.70988842 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.56541566 |
| 5 | MP0005365_abnormal_bile_salt | 4.11834919 |
| 6 | MP0003646_muscle_fatigue | 3.76013549 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.25138829 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.24705138 |
| 9 | MP0000749_muscle_degeneration | 2.77851123 |
| 10 | MP0003252_abnormal_bile_duct | 2.74555340 |
| 11 | MP0000751_myopathy | 2.62277236 |
| 12 | MP0005083_abnormal_biliary_tract | 2.47822407 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.36211508 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.34914987 |
| 15 | MP0005332_abnormal_amino_acid | 2.28334026 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.24319472 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.16432552 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.15991312 |
| 19 | MP0003283_abnormal_digestive_organ | 2.12976681 |
| 20 | MP0009840_abnormal_foam_cell | 2.12876385 |
| 21 | MP0002269_muscular_atrophy | 2.11900262 |
| 22 | MP0005330_cardiomyopathy | 2.07580164 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.95409090 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.94456965 |
| 25 | MP0004087_abnormal_muscle_fiber | 1.88562085 |
| 26 | MP0004130_abnormal_muscle_cell | 1.82283522 |
| 27 | MP0003195_calcinosis | 1.79388716 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.78493002 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.73140668 |
| 30 | MP0000013_abnormal_adipose_tissue | 1.72658713 |
| 31 | MP0002106_abnormal_muscle_physiology | 1.65889871 |
| 32 | MP0000747_muscle_weakness | 1.65319246 |
| 33 | MP0005451_abnormal_body_composition | 1.64522748 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.60557210 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.56205551 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.56194018 |
| 37 | MP0004510_myositis | 1.48745952 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.47759792 |
| 39 | MP0005266_abnormal_metabolism | 1.44167048 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.42305316 |
| 41 | MP0000759_abnormal_skeletal_muscle | 1.41564214 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.39970319 |
| 43 | MP0000609_abnormal_liver_physiology | 1.39423687 |
| 44 | MP0001661_extended_life_span | 1.37211550 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.37030353 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.36527309 |
| 47 | MP0005369_muscle_phenotype | 1.34337622 |
| 48 | MP0003186_abnormal_redox_activity | 1.32541568 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.31441029 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.29410539 |
| 51 | MP0010630_abnormal_cardiac_muscle | 1.27087192 |
| 52 | MP0002972_abnormal_cardiac_muscle | 1.25359851 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.22176533 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.19063991 |
| 55 | MP0009053_abnormal_anal_canal | 1.18207122 |
| 56 | MP0005670_abnormal_white_adipose | 1.16904534 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13827639 |
| 58 | MP0001544_abnormal_cardiovascular_syste | 1.12394907 |
| 59 | MP0005385_cardiovascular_system_phenoty | 1.12394907 |
| 60 | MP0003137_abnormal_impulse_conducting | 1.11713041 |
| 61 | MP0004233_abnormal_muscle_weight | 1.09011393 |
| 62 | MP0008775_abnormal_heart_ventricle | 1.07871951 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.07643229 |
| 64 | MP0003879_abnormal_hair_cell | 1.07264765 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.05021416 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.02374052 |
| 67 | MP0002876_abnormal_thyroid_physiology | 0.99115396 |
| 68 | MP0001764_abnormal_homeostasis | 0.96174960 |
| 69 | MP0002127_abnormal_cardiovascular_syste | 0.95492194 |
| 70 | MP0002234_abnormal_pharynx_morphology | 0.91915063 |
| 71 | MP0006138_congestive_heart_failure | 0.87756846 |
| 72 | MP0003868_abnormal_feces_composition | 0.86339000 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.86096337 |
| 74 | MP0004043_abnormal_pH_regulation | 0.85498115 |
| 75 | MP0002822_catalepsy | 0.85312888 |
| 76 | MP0000598_abnormal_liver_morphology | 0.82457845 |
| 77 | MP0003045_fibrosis | 0.81923221 |
| 78 | MP0004484_altered_response_of | 0.81517338 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.78935376 |
| 80 | MP0004270_analgesia | 0.78425127 |
| 81 | MP0002796_impaired_skin_barrier | 0.73691844 |
| 82 | MP0002108_abnormal_muscle_morphology | 0.73417794 |
| 83 | MP0003011_delayed_dark_adaptation | 0.71857785 |
| 84 | MP0002971_abnormal_brown_adipose | 0.71567447 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.69880201 |
| 86 | MP0001756_abnormal_urination | 0.69584529 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.66472797 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 0.65192845 |
| 89 | MP0002896_abnormal_bone_mineralization | 0.64897393 |
| 90 | MP0003718_maternal_effect | 0.64707866 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.62536713 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.58538048 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.58517947 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.58049415 |
| 95 | MP0008438_abnormal_cutaneous_collagen | 0.57533170 |
| 96 | MP0004133_heterotaxia | 0.57424977 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.55091843 |
| 98 | MP0005166_decreased_susceptibility_to | 0.54995092 |
| 99 | MP0000266_abnormal_heart_morphology | 0.52813370 |
| 100 | MP0005165_increased_susceptibility_to | 0.52361808 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.51850099 |
| 102 | MP0009697_abnormal_copulation | 0.49972914 |
| 103 | MP0003828_pulmonary_edema | 0.49872087 |
| 104 | MP0000762_abnormal_tongue_morphology | 0.49791500 |
| 105 | MP0002128_abnormal_blood_circulation | 0.49451810 |
| 106 | MP0000343_altered_response_to | 0.48246867 |
| 107 | MP0005334_abnormal_fat_pad | 0.48198964 |
| 108 | MP0004085_abnormal_heartbeat | 0.47991442 |
| 109 | MP0009672_abnormal_birth_weight | 0.47521713 |
| 110 | MP0005275_abnormal_skin_tensile | 0.47375238 |
| 111 | MP0004272_abnormal_basement_membrane | 0.47112665 |
| 112 | MP0009763_increased_sensitivity_to | 0.45124717 |
| 113 | MP0005647_abnormal_sex_gland | 0.44814624 |
| 114 | MP0005395_other_phenotype | 0.44588421 |
| 115 | MP0000733_abnormal_muscle_development | 0.43554417 |
| 116 | MP0002254_reproductive_system_inflammat | 0.43272698 |
| 117 | MP0002249_abnormal_larynx_morphology | 0.43148293 |
| 118 | MP0004134_abnormal_chest_morphology | 0.42878571 |
| 119 | MP0009384_cardiac_valve_regurgitation | 0.41326019 |
| 120 | MP0003941_abnormal_skin_development | 0.41186055 |
| 121 | MP0004858_abnormal_nervous_system | 0.39326202 |
| 122 | MP0002168_other_aberrant_phenotype | 0.39318633 |
| 123 | MP0005535_abnormal_body_temperature | 0.37794854 |
| 124 | MP0002132_abnormal_respiratory_system | 0.37657209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.20381947 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.98590704 |
| 3 | Myoglobinuria (HP:0002913) | 4.41321882 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.41209490 |
| 5 | Hyperglycinuria (HP:0003108) | 4.20450086 |
| 6 | Neck muscle weakness (HP:0000467) | 4.16717975 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.12844875 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.07551801 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.06864375 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.05872478 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 4.01191552 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 3.94515728 |
| 13 | Hyperammonemia (HP:0001987) | 3.90134969 |
| 14 | Hyperglycinemia (HP:0002154) | 3.89632947 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.81544945 |
| 16 | Rhabdomyolysis (HP:0003201) | 3.79924941 |
| 17 | Xanthomatosis (HP:0000991) | 3.79144093 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.75856274 |
| 19 | Calcaneovalgus deformity (HP:0001848) | 3.75095016 |
| 20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.71921565 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.70062181 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.70062181 |
| 23 | Ketosis (HP:0001946) | 3.65402346 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 3.55480810 |
| 25 | Rimmed vacuoles (HP:0003805) | 3.55398916 |
| 26 | Hyporeflexia of lower limbs (HP:0002600) | 3.55113800 |
| 27 | Muscle fiber splitting (HP:0003555) | 3.50223728 |
| 28 | Sudden death (HP:0001699) | 3.44542472 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.41074248 |
| 30 | Ventricular tachycardia (HP:0004756) | 3.37491295 |
| 31 | Nemaline bodies (HP:0003798) | 3.36536104 |
| 32 | Deformed tarsal bones (HP:0008119) | 3.28903205 |
| 33 | Ketoacidosis (HP:0001993) | 3.25851874 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.19691094 |
| 35 | Hypolipoproteinemia (HP:0010981) | 3.18914379 |
| 36 | Malignant hyperthermia (HP:0002047) | 3.18081226 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 3.15885049 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 3.13864484 |
| 39 | Gout (HP:0001997) | 3.09921046 |
| 40 | Increased connective tissue (HP:0009025) | 3.09791855 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.06715680 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.06715680 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.06611334 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 3.01777907 |
| 45 | Right ventricular cardiomyopathy (HP:0011663) | 2.96188336 |
| 46 | Bundle branch block (HP:0011710) | 2.95382915 |
| 47 | Muscle stiffness (HP:0003552) | 2.94510034 |
| 48 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.92959337 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.89968890 |
| 50 | Cerebral edema (HP:0002181) | 2.88305052 |
| 51 | Abnormal cartilage morphology (HP:0002763) | 2.85337613 |
| 52 | Prolonged partial thromboplastin time (HP:0003645) | 2.83489311 |
| 53 | Difficulty running (HP:0009046) | 2.80215407 |
| 54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.76274168 |
| 55 | Abnormality of the calf musculature (HP:0001430) | 2.75782256 |
| 56 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.74435746 |
| 57 | EMG: myopathic abnormalities (HP:0003458) | 2.73447441 |
| 58 | Absent phalangeal crease (HP:0006109) | 2.73218540 |
| 59 | Hyperkalemia (HP:0002153) | 2.72518413 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.71273524 |
| 61 | EMG: neuropathic changes (HP:0003445) | 2.70108355 |
| 62 | Frequent falls (HP:0002359) | 2.68446156 |
| 63 | Lethargy (HP:0001254) | 2.67749769 |
| 64 | Bulbar palsy (HP:0001283) | 2.66235157 |
| 65 | Metabolic acidosis (HP:0001942) | 2.60550015 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 2.59260155 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.56182125 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 2.53727887 |
| 69 | Distal arthrogryposis (HP:0005684) | 2.52693448 |
| 70 | Round ear (HP:0100830) | 2.49171580 |
| 71 | Generalized muscle weakness (HP:0003324) | 2.48539275 |
| 72 | Myopathic facies (HP:0002058) | 2.47582434 |
| 73 | Complement deficiency (HP:0004431) | 2.45310888 |
| 74 | Increased purine levels (HP:0004368) | 2.44660694 |
| 75 | Hyperuricemia (HP:0002149) | 2.44660694 |
| 76 | Posterior subcapsular cataract (HP:0007787) | 2.44343232 |
| 77 | Popliteal pterygium (HP:0009756) | 2.41626395 |
| 78 | Myotonia (HP:0002486) | 2.41540633 |
| 79 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.40647792 |
| 80 | Acute encephalopathy (HP:0006846) | 2.40237188 |
| 81 | Gowers sign (HP:0003391) | 2.39547979 |
| 82 | Increased muscle lipid content (HP:0009058) | 2.39396208 |
| 83 | Fetal akinesia sequence (HP:0001989) | 2.38659245 |
| 84 | Lipoatrophy (HP:0100578) | 2.36954742 |
| 85 | Hip contracture (HP:0003273) | 2.36764201 |
| 86 | Distal lower limb muscle weakness (HP:0009053) | 2.36595049 |
| 87 | Abnormality of purine metabolism (HP:0004352) | 2.36226244 |
| 88 | Palpitations (HP:0001962) | 2.35900545 |
| 89 | Abnormality of nucleobase metabolism (HP:0010932) | 2.32785568 |
| 90 | Fat malabsorption (HP:0002630) | 2.29799529 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 2.29358199 |
| 92 | Subaortic stenosis (HP:0001682) | 2.28888387 |
| 93 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.28888387 |
| 94 | Hepatic necrosis (HP:0002605) | 2.28641179 |
| 95 | Areflexia of lower limbs (HP:0002522) | 2.28491091 |
| 96 | Cholelithiasis (HP:0001081) | 2.28189494 |
| 97 | Epidermoid cyst (HP:0200040) | 2.27055039 |
| 98 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.25904217 |
| 99 | Limb-girdle muscle atrophy (HP:0003797) | 2.23844646 |
| 100 | Abnormality of the calcaneus (HP:0008364) | 2.22527388 |
| 101 | Delayed CNS myelination (HP:0002188) | 2.18845098 |
| 102 | Fatigable weakness (HP:0003473) | 2.17952175 |
| 103 | Abnormality of the neuromuscular junction (HP:0003398) | 2.17952175 |
| 104 | Late onset (HP:0003584) | 2.17517358 |
| 105 | Weak cry (HP:0001612) | 2.15755275 |
| 106 | Abnormal finger flexion creases (HP:0006143) | 2.13223034 |
| 107 | Scapular winging (HP:0003691) | 2.13161786 |
| 108 | Increased intramyocellular lipid droplets (HP:0012240) | 2.12723801 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 2.12317498 |
| 110 | Ulnar deviation of the wrist (HP:0003049) | 2.12111585 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.10530950 |
| 112 | Dilated cardiomyopathy (HP:0001644) | 2.10226775 |
| 113 | Generalized aminoaciduria (HP:0002909) | 2.09586115 |
| 114 | Difficulty climbing stairs (HP:0003551) | 2.06013476 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 2.04309586 |
| 116 | Malnutrition (HP:0004395) | 2.03794977 |
| 117 | Proximal tubulopathy (HP:0000114) | 2.02389309 |
| 118 | Spinal rigidity (HP:0003306) | 2.02205161 |
| 119 | Heart block (HP:0012722) | 2.01672683 |
| 120 | Slender build (HP:0001533) | 2.01097521 |
| 121 | Abnormal atrioventricular conduction (HP:0005150) | 1.98804398 |
| 122 | Vomiting (HP:0002013) | 1.98540397 |
| 123 | Breech presentation (HP:0001623) | 1.96617042 |
| 124 | Flat acetabular roof (HP:0003180) | 1.95947451 |
| 125 | Hyperbilirubinemia (HP:0002904) | 1.95762820 |
| 126 | Hyperglycemia (HP:0003074) | 1.94709297 |
| 127 | Hypercholesterolemia (HP:0003124) | 1.91812274 |
| 128 | Skin nodule (HP:0200036) | 1.90725351 |
| 129 | Joint hemorrhage (HP:0005261) | 1.89607312 |
| 130 | Nausea (HP:0002018) | 1.89035472 |
| 131 | Ventricular arrhythmia (HP:0004308) | 1.85996432 |
| 132 | Progressive muscle weakness (HP:0003323) | 1.83245804 |
| 133 | Waddling gait (HP:0002515) | 1.80551057 |
| 134 | Proximal amyotrophy (HP:0007126) | 1.78804410 |
| 135 | Abnormality of the foot musculature (HP:0001436) | 1.77741755 |
| 136 | Limited hip movement (HP:0008800) | 1.76016008 |
| 137 | Muscular dystrophy (HP:0003560) | 1.75568038 |
| 138 | Metatarsus adductus (HP:0001840) | 1.74944974 |
| 139 | Foot dorsiflexor weakness (HP:0009027) | 1.68358984 |
| 140 | Abnormality of complement system (HP:0005339) | 1.66851207 |
| 141 | Nonprogressive disorder (HP:0003680) | 1.57625466 |
| 142 | Abnormality of potassium homeostasis (HP:0011042) | 1.56422179 |
| 143 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.56056036 |
| 144 | Abnormality of the Achilles tendon (HP:0005109) | 1.54190733 |
| 145 | Long clavicles (HP:0000890) | 1.51751475 |
| 146 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.51564799 |
| 147 | Lower limb amyotrophy (HP:0007210) | 1.45327617 |
| 148 | Facial diplegia (HP:0001349) | 1.42771798 |
| 149 | Ulnar deviation of finger (HP:0009465) | 1.42082759 |
| 150 | Limb-girdle muscle weakness (HP:0003325) | 1.40160193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 6.90901063 |
| 2 | BCKDK | 5.00667420 |
| 3 | OBSCN | 4.60321692 |
| 4 | TTN | 4.32852099 |
| 5 | PHKG1 | 2.86410777 |
| 6 | PHKG2 | 2.86410777 |
| 7 | NEK1 | 2.73082164 |
| 8 | PDK3 | 2.35374280 |
| 9 | PDK4 | 2.35374280 |
| 10 | PKN2 | 2.13456623 |
| 11 | EPHB2 | 2.07872842 |
| 12 | PINK1 | 2.04190283 |
| 13 | STK38L | 1.66616697 |
| 14 | PDK2 | 1.63208334 |
| 15 | PIK3CG | 1.58855941 |
| 16 | MAP2K3 | 1.54813069 |
| 17 | TRIB3 | 1.54197597 |
| 18 | ERN1 | 1.48746987 |
| 19 | PIK3CA | 1.47643597 |
| 20 | EEF2K | 1.42612635 |
| 21 | MYLK | 1.42481501 |
| 22 | NME1 | 1.37300431 |
| 23 | EPHA2 | 1.34310915 |
| 24 | RIPK1 | 1.33128537 |
| 25 | MAP3K7 | 1.28621958 |
| 26 | MAPKAPK3 | 1.28521044 |
| 27 | TRPM7 | 1.27957681 |
| 28 | ICK | 1.23425598 |
| 29 | FLT3 | 1.23413635 |
| 30 | LMTK2 | 1.21042176 |
| 31 | SIK1 | 1.16311857 |
| 32 | FGFR4 | 1.11857225 |
| 33 | MST1R | 1.08903528 |
| 34 | MAPK11 | 1.05568118 |
| 35 | ZAK | 1.02197111 |
| 36 | MAP3K3 | 1.01105158 |
| 37 | PRKAA2 | 0.99354287 |
| 38 | LIMK1 | 0.99349583 |
| 39 | MAP3K11 | 0.95899431 |
| 40 | CDK12 | 0.95670104 |
| 41 | MAP2K2 | 0.93693821 |
| 42 | DMPK | 0.93416992 |
| 43 | MAP2K6 | 0.91824528 |
| 44 | MAPK12 | 0.89918473 |
| 45 | LATS1 | 0.89679129 |
| 46 | TTK | 0.89297556 |
| 47 | LATS2 | 0.87341153 |
| 48 | MAP2K4 | 0.85209017 |
| 49 | PRKAA1 | 0.84822340 |
| 50 | ERBB4 | 0.80223057 |
| 51 | FGFR3 | 0.74045914 |
| 52 | RPS6KB2 | 0.73449243 |
| 53 | PTK6 | 0.72922019 |
| 54 | TIE1 | 0.72206731 |
| 55 | EPHB1 | 0.69601202 |
| 56 | STK24 | 0.69307825 |
| 57 | ILK | 0.69121952 |
| 58 | MET | 0.65502241 |
| 59 | GRK6 | 0.64972746 |
| 60 | NEK9 | 0.62060011 |
| 61 | MOS | 0.60049201 |
| 62 | PDPK1 | 0.59523523 |
| 63 | AKT2 | 0.59295138 |
| 64 | MAP3K13 | 0.59119292 |
| 65 | TESK1 | 0.58472483 |
| 66 | MARK2 | 0.57838716 |
| 67 | MTOR | 0.57052490 |
| 68 | TAOK1 | 0.56992400 |
| 69 | MAPK15 | 0.56414706 |
| 70 | TBK1 | 0.53360654 |
| 71 | SGK3 | 0.52920865 |
| 72 | INSRR | 0.52338662 |
| 73 | CDC42BPA | 0.52155353 |
| 74 | TAOK2 | 0.51256225 |
| 75 | MAP3K8 | 0.51250192 |
| 76 | FER | 0.51097159 |
| 77 | NME2 | 0.51031203 |
| 78 | AKT3 | 0.50584723 |
| 79 | KDR | 0.50398598 |
| 80 | PRKG1 | 0.48747270 |
| 81 | ERBB3 | 0.48153874 |
| 82 | ROCK1 | 0.46944530 |
| 83 | CCNB1 | 0.45619258 |
| 84 | CAMK2G | 0.45277951 |
| 85 | ABL2 | 0.44008211 |
| 86 | MAP3K10 | 0.43767679 |
| 87 | WEE1 | 0.43309356 |
| 88 | DDR2 | 0.42540023 |
| 89 | PRKD1 | 0.41197132 |
| 90 | SGK1 | 0.40745552 |
| 91 | WNK4 | 0.40177750 |
| 92 | EPHA3 | 0.39253608 |
| 93 | AURKB | 0.39129213 |
| 94 | PLK1 | 0.38754051 |
| 95 | STK4 | 0.38379978 |
| 96 | MAP3K5 | 0.38273400 |
| 97 | MAP3K1 | 0.37176640 |
| 98 | PDK1 | 0.36644957 |
| 99 | MAPK4 | 0.36550467 |
| 100 | CDK4 | 0.35562699 |
| 101 | TNK2 | 0.35189397 |
| 102 | SGK2 | 0.34703438 |
| 103 | PRKG2 | 0.33981302 |
| 104 | PRKACG | 0.33805876 |
| 105 | CDK7 | 0.33579833 |
| 106 | MAP3K2 | 0.33066741 |
| 107 | SGK223 | 0.33041171 |
| 108 | SGK494 | 0.33041171 |
| 109 | MAPK7 | 0.33024658 |
| 110 | TGFBR2 | 0.32799323 |
| 111 | PAK4 | 0.32619449 |
| 112 | NLK | 0.32604202 |
| 113 | STK10 | 0.32005884 |
| 114 | PRKACA | 0.31655271 |
| 115 | MAP3K6 | 0.31635865 |
| 116 | KSR2 | 0.31211333 |
| 117 | PTK2 | 0.30938827 |
| 118 | PDGFRA | 0.28817950 |
| 119 | CAMK1 | 0.28255800 |
| 120 | PRPF4B | 0.28240282 |
| 121 | MAP2K1 | 0.27857834 |
| 122 | GSK3A | 0.27634167 |
| 123 | RPS6KA1 | 0.26931837 |
| 124 | PRKACB | 0.26772880 |
| 125 | DAPK3 | 0.25918253 |
| 126 | RPS6KA3 | 0.25707836 |
| 127 | MUSK | 0.25681115 |
| 128 | ZAP70 | 0.25245365 |
| 129 | CAMK2A | 0.25001533 |
| 130 | TYK2 | 0.24187504 |
| 131 | CAMK2D | 0.23774070 |
| 132 | RPS6KB1 | 0.23177185 |
| 133 | STK38 | 0.22994173 |
| 134 | GRK7 | 0.22222065 |
| 135 | BMX | 0.21671479 |
| 136 | CAMK2B | 0.21539757 |
| 137 | CAMK4 | 0.21321320 |
| 138 | RPS6KA2 | 0.21090913 |
| 139 | DYRK1B | 0.19675004 |
| 140 | ERBB2 | 0.19443871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.66890474 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.10295616 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.09427981 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.92389463 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.88746936 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.80240205 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.78375206 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66454021 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.57092827 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.56503033 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.51416273 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34918182 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31376514 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.07415137 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06482993 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98949389 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85916895 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85465593 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.82896944 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.78998644 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72340270 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72128565 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70414758 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.65156034 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.61891490 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59643190 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59302780 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58601295 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58501576 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52858597 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51615970 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46485980 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44972462 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40384196 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40123205 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37906031 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37496340 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.37304427 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36612295 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33528152 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31178929 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.22877281 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21329594 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19035151 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17404854 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17144206 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.15549305 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12032446 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10925358 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10000645 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09462876 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09085604 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06817927 |
| 54 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06356888 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03714825 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03110832 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99962419 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97227021 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90199410 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89058356 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87686398 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.84163977 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82663144 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72955042 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72659919 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70608016 |
| 67 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69912326 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69450326 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66472886 |
| 70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65992423 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64856721 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64830830 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.64145276 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63787149 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63204417 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62806899 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62286464 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61487188 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58779605 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57594180 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56168095 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53998422 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51322187 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.50623006 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.48269658 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47827861 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47379515 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45252379 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.45205588 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42612181 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41397556 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41225434 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39830370 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39759831 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37010799 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35020624 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31857639 |
| 98 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31380485 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30948746 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30340786 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29607999 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28896263 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27499105 |
| 104 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.26782008 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.24036294 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23362907 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.19258082 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10039477 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09178132 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08470323 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.05136626 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.04207240 |
| 113 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04177750 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.00784481 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0469504 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | -0.0272243 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0110108 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0055223 |

